血液透析通路狭窄的发生机制及防治

doi:10.16139/j.1007-9610.2019.04.002

摘要/Abstract

中图分类号:

R654.3

樊雪强, 刘鹏. 血液透析通路狭窄的发生机制及防治[J]. 外科理论与实践, 2019, 24(04): 289-292.

[1] Wang F, Chao Y, Long JY, et al.Executive summary for the 2015 Annual Date Report of the China Kidney Di-sease Network(CK-NET)[J]. Kidney Int,2019,95(3):501-505.
[2] Dwsai M, Mirzay-Razzaz J, Von Delft D, et al.Inhibition of neointimal formation and hyperplasia in vein grafts by extemal stent/sheath[J]. Vasc Med,2010,15(4):287-297.
[3] Roy-Chaudhury P, Sukhatme VP, Cheung AK.Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint[J]. J Am Soc Nephrol,2006,17(4):1112-1127.
[4] 胡佳, 郭应强, 张尔永, 等. 流场压力变化对体外培养内皮细胞增殖和调亡及其相关蛋白的影响[J]. 生物医学工程学杂志,2009,26(4):836-841.
[5] Misra S, Fu AA, Rajan DK, et al.Expression of hypoxia inducible factor-1 alpha, macrophage migration inhibition factor, matrix metalloproteinase-2 and -9, and their inhibitors in hemodialysis grafts and arteriovenous fistulas[J]. J Vasc Interv Radiol,2008,19(2):252-259.
[6] Rotmans JI, Velema E, Verhagen HJ, et al.Matrix metalloproteinase inhibition reduces intimal hyperplasia in a porcine arteriovenous-graft model[J]. J Vasc Surg,2004, 39(2):432-439.
[7] Castier Y, Brandes RP, Leseche G, et al.p47phox- dependent NADPH oxidase regulates flow-induced vascular remodeling[J]. Circ Res,2005,97(6):533-540.
[8] Weiss MF, Scivittaro V, Anderson JM.Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access[J]. Am J Kidney Dis,2001,37(5):970-980.
[9] Stracke S, Konner K, Kostlin I, et al.Increased expression of TGF-beta1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas[J]. Kidney Int,2002,61(3):1011-1019.
[10] Ghiadoni L, Cupisti A, Huang Y, et al.Endothelial dysfunction and oxidative stress in chronic renal failure[J]. J Nephrol,2004,17(4):512-519.
[11] Kordzadeh A, Panayiotopolous Y.S-shaped versus conventional straight skin incision: Impact on primary functional maturation, stenosis and thrombosis of autogenous radiocephalic arteriovenous fistula: Impact of incision on maturation, stenosis & failure of RCAVF. Study design: Prospective observational comparative[J]. Ann Med Surg (Lond),2017,22:16-21.
[12] Samano N, Geijer H, Liden M, et al.The no-touch saphenous vein for coronary artery bypass grafting maintains a patency, after 16 years, comparable to the left internal thoracic artery: A randomized trial[J]. J Thorac Cardiovasc Surg,2015,150(4):880-888.
[13] Ene-Iordache B, Cattaneo L, Dubini G, et al.Effect of anastomosis angle on the localization of disturbed flow in “side-to-end” fistulae for haemodialysis access[J]. Nephrol Dial Transplant,2013,28(4):997-1005.
[14] Krishnamoorthy MK, Banerjee RK, Wang Y, et al.Hemodynamic wall shear stress profiles influence the magnitude and pattern of stenosis in a pig AV fistula[J]. Kidney Int,2008,74(11):1410-1419.
[15] Sadaghianloo N, Declemy S, Jean-Baptiste E, et al.Radial artery deviation and reimplantation inhibits venous juxta-anastomotic stenosis and increases primary patency of radial-cephalic fistulas for hemodialysis[J]. J Vasc Surg,2016,64(3):698-706.
[16] Dember LM, Beck GJ, Allon M, et al.Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: A randomized controlled trial[J]. JAMA,2008,299(18):2164-2171.
[17] Dixon BS, Beck GJ, Dember LM, et al.Design of the Dialysis Access Consortium(DAC) Aggrenox Prevention of Access Stenosis Trial[J]. Clin Trials,2005,2(5):400-412.
[18] Crowther MA, Clase CM, Margetts PJ, et al.Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: a randomized controlled trial[J]. J Am Soc Nephrol,2002,13(9):2331-2337.
[19] Gradzki R, Dhingra RK, Port FK, et al.Use of ACE inhibitors is associated with prolonged survival of arterio-venous grafts[J]. Am J Kidney Dis,2001,38(6):1240-1244.
[20] Sajgure A, Choudhury A, Ahmed Z, et al.Angiotensin converting enzyme inhibitors maintain polytetrafluroethylene graft patency[J]. Nephrol Dial Transplant,2007,22(5):1390-1398.
[21] Tordoir JHM, Bode AS, Peppelenbosch N, et al.Surgical or endovascular repair of thrombosed dialysis vascular access: is there any evidence?[J]. J Vasc Surg,2009,50(4):953-956.
[22] Khawaja AZ, Cassidy DB, Shakarchi JA, et al.Systematic review of drug eluting balloon angioplasty for arteriovenous haemodialysis access stenosis[J]. J Vasc Access,2016,17(2):103-110.
[23] Phang CC, Tan RY, Pang SC, et al. Paclitaxel-coated balloon in the treatment of recurrent dysfunctional arteriovenous access, real-world experience and longitudinal follow up[J]. Nephrology (Carlton),2019-03-22[Epub ahead of print]

血液透析通路狭窄的发生机制及防治

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	叶鸿庆, 苏华德, 郑美妹, 夏唐斌. 考虑双供应商的维护和备件订购联合决策优化[J]. 上海交通大学学报, 2022, 56(10): 1359-1367.
[2]	宋景涌汤鹏钟晓捷刘侠孙洋亢玉王遥佳陈安玥陈怡安吉训通周艳虹蒋曼妃修骋穆籣. 吻合口通畅性量化分析应用于乳腺癌腋窝淋巴结清扫术同期预防性淋巴管静脉吻合1例[J]. 组织工程与重建外科杂志, 2022, 18(1): 34-.
[3]	陈嘉仪, 周增丁, 曹伟伟, 赵小婕, 梁晓虹, 王正廷, 项晓刚, 郭颖. 新型冠状病毒肺炎疫情下普通医院转定点医院闭环工作人员管理防控经验[J]. 内科理论与实践, 2022, 17(02): 159-163.
[4]	张祎博, 吴文娟, 毕宇芳, 景峰, 顾志冬, 杨之涛, 尚寒冰, 林靖生, 陈尔真. 大型方舱医院感染预防与控制体系的建设和实践探索[J]. 诊断学理论与实践, 2022, 21(02): 165-168.
[5]	庄蕾, 高卫益. 新型冠状病毒肺炎疫情期间非定点医疗机构“分区管理”策略[J]. 诊断学理论与实践, 2022, 21(02): 245-247.
[6]	王亦晨, 周剑平, 杨振华, 王敏慧, 刘佳, 倪语星, 张祎博, 石大可, 徐玉敏. 新型冠状病毒肺炎救治临时定点医院工作人员医院感染防控管理方案[J]. 诊断学理论与实践, 2022, 21(02): 270-272.
[7]	付朝伟. 阿尔茨海默病重在预防——《中国阿尔茨海默病报告2021》解读[J]. 诊断学理论与实践, 2022, 21(01): 8-11.
[8]	钟小波, 于龙, 吕顺, 牟文通, 朱岩峰. 秦山核电功能设备组的创建及应用[J]. 上海交通大学学报, 2021, 55(S2): 1-6.
[9]	王金凤, 陈璐, 杨雯慧. 考虑设备可用性约束的单机调度问题[J]. 上海交通大学学报, 2021, 55(1): 103-110.
[10]	温晓峰, 吴现瑞, 兰平. 再论直肠癌术后吻合口漏的危险因素及预防新策略[J]. 外科理论与实践, 2021, 26(04): 285-289.
[11]	李磊, 刘一云, 张如愿, 汤耀卿. 碳青霉烯类抗生素预防重症急性胰腺炎感染的研究[J]. 外科理论与实践, 2021, 26(04): 348-352.
[12]	王墨扬, 陈阳, 叶蕴青, 张洪亮, 吴永健. 主动脉瓣狭窄合并冠心病患者的经导管主动脉瓣置换联合介入治疗[J]. 内科理论与实践, 2021, 16(03): 151-154.
[13]	祝米鑫, 葛亚雄, 周晓军. 动态生产计划下多工序柔性制造系统预防维护决策[J]. 上海交通大学学报, 2020, 54(11): 1124-1133.
[14]	苏春，赵家彬. 基于产品使用率的柔性基本质保策略优化设计[J]. 上海交通大学学报, 2020, 54(11): 1182-1188.
[15]	俞梦琦，史凯龙，周晓军. 基于双时间窗的多设备串行系统机会维护策略[J]. 上海交通大学学报, 2020, 54(1): 69-75.